Publications by authors named "David Walk"

Claim this Profile
M
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis.
Brooke Krivickas, Erica Scirocco, Elisa Giacomelli, Saloni Sharma, Molly Benson, David Walk

Muscle Nerve· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.
Gang Wu, Wenan Chen, Joanne Wuu, Angita Jain, Jason Myers, David Walk

Transl Neurodegener· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment.
Ikjae Lee, Grace Jang, Ying Kuen Ken Cheung, Alexander V Sherman, Wendy S Johnston, David Walk

Ann Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium dataset.
David Schneck, Andres Arguedas, Annette Xenopoulos-Oddsson, Ximena Arcila-Londono, Christian Lunetta, David Walk

Amyotroph Lateral Scler Frontotemporal Degener· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.
Andres Arguedas, David Schneck, Erjia Cui, Annette Xenopoulos-Oddsson, Ximena Arcila-Londono, David Walk

Amyotroph Lateral Scler Frontotemporal Degener· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy.
Marianela Schiava, Yolande Parkhurst, Matthew Henderson, Tuomo Polvikoski, Manouela V Valtcheva, David Walk

Neurol Genet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Resolution Photoelectron Spectroscopy of the XΣ Ground State of CaAr.
Joel R Schmitz, David Walk, Frédéric Merkt

J Phys Chem A· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.
Neil A Shneider, Matthew B Harms, Vlad A Korobeynikov, Olivia M Rifai, Benjamin N Hoover, David Walk

Lancet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charcot-Marie-Tooth disease type 1E: clinical natural history and molecular impact of PMP22 variants.
Kailee S Ward, Christopher P Ptak, Natalya Pashkova, Tiffany Grider, Tabitha A Peterson, David Walk

Brain· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charcot-Marie-Tooth disease type 1E: Clinical Natural History and Molecular Impact of Variants.
Kailee S Ward, Christopher P Ptak, Natalya Pashkova, Tiffany Grider, Tabitha A Peterson, David Walk

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.

JAMA Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, Lori B Chibnik, Melanie Quintana, David Walk

JAMA Netw Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations.
Gage P Kosmanopoulos, Jack K Donohue, Maya Hoke, Simone Thomas, Margo A Peyton, David Walk

Brain· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.
Shahram Attarian, Peter Young, Thomas H Brannagan, David Adams, Philip Van Damme, David Walk

Orphanet J Rare Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants.
Christopher J Record, Mariola Skorupinska, Matilde Laura, Alexander M Rossor, Davide Pareyson, David Walk

Brain· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy.
Marianela Schiava, Chiseko Ikenaga, Ana Topf, Marta Caballero-Ávila, Tsui-Fen Chou, David Walk

Neurol Genet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary lateral sclerosis natural history study - planning, designing, and early enrollment.
Hiroshi Mitsumoto, Grace Jang, Ikjae Lee, Zachary Simmons, Alexander V Sherman, David Walk

Amyotroph Lateral Scler Frontotemporal Degener· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The natural history of ALS: Baseline characteristics from a multicenter clinical cohort.
Alex Berger, Matteo Locatelli, Ximena Arcila-Londono, Ghazala Hayat, Nicholas Olney, David Walk

Amyotroph Lateral Scler Frontotemporal Degener· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal MRI improves diagnostic accuracy and sensitivity to longitudinal change in amyotrophic lateral sclerosis.
Pramod Kumar Pisharady, Lynn E Eberly, Isaac M Adanyeguh, Georgios Manousakis, Gaurav Guliani, David Walk

Commun Med (Lond)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis.
David Walk, Katharine Nicholson, Eduardo Locatelli, James Chan, Eric A Macklin, Daniela Grasso Walker, Jason Walker

Muscle Nerve· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses.
Robert G Miller, Rongzhen Zhang, Paige M Bracci, Ari Azhir, Richard Barohn, David Walk

Muscle Nerve· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease.
Florian P Thomas, Thomas H Brannagan, Russell J Butterfield, Urvi Desai, Ali A Habib, David Walk

Neurology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the power of the electronic health record for ALS research and quality improvement: CReATe CAPTURE-ALS and the ALS Toolkit.
Volkan Granit, Anne-Laure Grignon, Joanne Wuu, Jonathan Katz, David Walk

Muscle Nerve· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis